CBD Life Sciences Inc. (OTCMKTS:CBDL) Short Interest Up 8,233.3% in November

CBD Life Sciences Inc. (OTCMKTS:CBDL) was the target of a significant growth in short interest in November. As of November 30th, there was short interest totalling 100,000 shares, a growth of 8,233.3% from the November 15th total of 1,200 shares. Based on an average trading volume of 110,766,700 shares, the short-interest ratio is currently 0.0 days.

CBD Life Sciences Price Performance

Shares of CBD Life Sciences stock remained flat at $0.00 on Wednesday. 6,871,766 shares of the stock traded hands, compared to its average volume of 13,246,205. CBD Life Sciences has a twelve month low of $0.00 and a twelve month high of $0.03.

CBD Life Sciences Company Profile

CBD Life Sciences Inc engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a line of pet products. The company is based in Scottsdale, Arizona.